Se
Servier
Suresnes FRFounded 195422,000 employees
Private CappharmaPrivateOncologyCardiology
Platform: Oncology Cardio
Market Cap
N/A
All Drugs
3
Clinical Trials
7
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Niratinib | SER-1225 | Preclinical | 1 | CD20 | CML | ||
| Pexainavolisib | SER-3679 | Phase 3 | 4 | TROP-2 | MG | ||
| Elracapivasertib | SER-3365 | Phase 1/2 | 2 | TIM-3 | OCD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (6)